EQS-News: APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 Preparation of program to increase operating performance and efficiency launched finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
EQS-News: APONTIS PHARMA AG / Key word(s): Change in Forecast/Profit WarningAPONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 – Preparation of program to increase operating performance and efficiency launched 27.07.2023 / 22:15 CET/CESTThe issuer is solely responsible for th.